TVGN — Tevogen Bio Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $182.46m
- $189.59m
Annual cashflow statement for Tevogen Bio Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -15.6 | -22 | -0.067 |
| Depreciation | |||
| Non-Cash Items | 11.6 | 13 | -2.21 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -1.25 | 0.258 | 0.898 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Cash from Operating Activities | -5.27 | -8.66 | -1.38 |
| Capital Expenditures | -0.11 | -0.479 | — |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | — | — | 343 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Cash from Investing Activities | -0.11 | -0.479 | 343 |
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 12.5 | 7.5 | -342 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 7.12 | -1.63 | -0.12 |